S12.5 Pill: red, capsule/oblong
The pill with imprint S12.5 (Red, Capsule/Oblong, 0mm) has been identified as Sunitinib Malate 12.5 mg and is used for Renal Cell Carcinoma, Gastrointestinal Stromal Tumor, and Pancreatic Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.
Images for S12.5
Sunitinib Malate
- Imprint
- S12.5
- Strength
- 12.5 mg
- Color
- Red (red opaque cap and red opaque body)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 59651-0464
Related images for "S12.5"
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.